Monkeys to be spared in some US drug trials
December 2, 2025
Excerpt:
The US’s drug regulator said it would stop requiring pharmaceutical companies to use lab monkeys for some safety studies, in a move that will yield substantial savings for the industry.
…
Last month, the UK announced a new strategy for replacing animals in drug testing, pledging £30mn in government funding to promote the use of artificial intelligence and other tools.
Naomi Charalambakis, an official with the non-profit Americans for Medical Progress, said the FDA would probably continue to require animal testing for complicated treatment developments for diseases such as Alzheimer’s and cancer.
“We have to ensure that any new approach that we use maintains or improves the safety and efficacy standards that we are already using rather than simply reducing animal use for the sake of reducing animal use,” Charalambakis said.
Patrick Temple-West, New York, The Financial Times Limited
‹ More News